A
Asto CT
High-quality volumetric imaging to improve quality of life for horses and ensure peace of mind for their owners
About Asto CT
Astoct.com specializes in providing advanced CT imaging solutions specifically designed for equine patients. The company's flagship product, Equina, offers high-quality images that detect early signs of stress responses in both bone and soft tissue. This technology is particularly beneficial for veterinarians and equine clinics, as it allows for weight-bearing scans of limb pairs up to the carpus or tarsus while the horse is standing. The scans are quick, taking 30 seconds or less, which means the entire process can be completed in under 10 minutes, minimizing stress for both the animal and the clinician.
Astoct.com operates in the veterinary imaging market and primarily serves equine veterinarians and clinics. The business model is based on a subscription service, which allows clinicians to install the Equina system without upfront costs and retain all the revenue generated from its use. This model provides a significant return on investment (ROI) for veterinary practices, making advanced imaging technology more accessible and financially viable.
The company generates revenue through its subscription fees, which cover the installation and maintenance of the Equina system. This approach ensures a steady income stream while providing clients with cutting-edge technology that enhances diagnostic capabilities.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Middleton, United States
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 73.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Spinout, Arts & Culture, DT and LS, science-based
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Computer Vision
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Jul 2021
- Capital deployed
- $25M
- Preferred round
- SERIES B
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Oct 2024 | $35M | $142M | Alumni Ventures · Mediquip | ↗ |
| SERIES BEquity / VC | May 2021 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Asto CT is 2K monthly website visits, down 4.8% over the last three months. Asto CT's team declined 8.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Serra Ventures
Series B and later2 investors entered at this stage
Alumni Ventures
Mediquip
Other known investors2 additional known investors
Morgridge
University of Wisconsin-Madison
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Asto CT on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Asto CT’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.